Asthma

Lungs
#Asthma #COPD #Drug delivery #Transpire Bio

Transpire Bio & Recipharm to develop inhaled medicines 

Pharmaceutical company Transpire Bio will work alongside drug delivery provider Recipharm to develop two inhaled medicines for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD).   Transpire Bio announced a definitive agreement with Recipharm to develop its TRB-1 and TRB-2 inhaled medicines. These are… Read More

#News

Woman reaches for inhaler
#Asthma #Data #Research

40% of asthma patients overusing inhalers, says data 

New results from an observational data analysis of asthma inhaler therapy found that short-acting beta2-agonist (SABA) reliever overuse is a global issue adversely impacting asthma outcomes.1,2   Data from across the SABA Use IN Asthma (SABINA) global programme have been published in The Journal of Allergy… Read More

#News #Trending News

#Asthma #AstraZeneca #Clinical trials

New data reinforce efficacy of asthma drug 

Results from a pooled post-hoc analysis of the pivotal NAVIGATOR Phase III and PATHWAY Phase IIb trials showed AstraZeneca and Amgen’s Tezspire (tezepelumab) demonstrated reductions in the annualised asthma exacerbation rate (AAER) across biomarker subgroups of patients with severe asthma.1 According to the company, these findings support… Read More

#News